Cargando…
Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α
OBJECTIVE: Mitochondrial reactive oxygen species (ROS) plays a key role in diabetic retinopathy (DR) pathogenesis. However, whether simvastatin decreases diabetes-induced mitochondrial ROS production remains uncertain. The aim of this study was to clarify the beneficial effects and mechanism of acti...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927955/ https://www.ncbi.nlm.nih.gov/pubmed/20566666 http://dx.doi.org/10.2337/db10-0638 |
_version_ | 1782185806963671040 |
---|---|
author | Zheng, Zhi Chen, Haibing Wang, Hong Ke, Bilian Zheng, Bingqing Li, Qian Li, Peiyu Su, Li Gu, Qing Xu, Xun |
author_facet | Zheng, Zhi Chen, Haibing Wang, Hong Ke, Bilian Zheng, Bingqing Li, Qian Li, Peiyu Su, Li Gu, Qing Xu, Xun |
author_sort | Zheng, Zhi |
collection | PubMed |
description | OBJECTIVE: Mitochondrial reactive oxygen species (ROS) plays a key role in diabetic retinopathy (DR) pathogenesis. However, whether simvastatin decreases diabetes-induced mitochondrial ROS production remains uncertain. The aim of this study was to clarify the beneficial effects and mechanism of action of simvastatin against diabetes-induced retinal vascular damage. RESEARCH DESIGN AND METHODS: Diabetic rats and control animals were randomly assigned to receive simvastatin or vehicle for 24 weeks, and bovine retinal capillary endothelial cells (BRECs) were incubated with normal or high glucose with or without simvastatin. Vascular endothelial growth factor (VEGF) and peroxisome proliferator–activated receptor γ coactivator 1α (PGC-1α) in the rat retinas or BRECs were examined by Western blotting and real-time RT-PCR, and poly (ADP-ribose) polymerase (PARP), and p38 MAPK were examined by Western blotting. Mitochondrial membrane potential (Δψm) and ROS production were assayed using the potentiometric dye 5,5′,6,6′- Tetrachloro1,1′,3,3′-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1) or CM-H(2)DCFDA fluorescent probes. RESULTS: Simvastatin significantly upregulated PGC-1α (P < 0.01), subsequently decreased Δψm (P < 0.05) and ROS generation (P < 0.01), inhibited PARP activation (P < 0.01), and further reduced VEGF expression (P < 0.01) and p38 MAPK activity (P < 0.01). Those changes were associated with the decrease of retinal vascular permeability, retinal capillary cells apoptosis, and formation of acellular capillaries. CONCLUSIONS: Simvastatin decreases diabetes-induced mitochondrial ROS production and exerts protective effects against early retinal vascular damage in diabetic rats in association with the inhibition of mitochondrial ROS/PARP pathway mediated by PGC-1α. The understanding of the mechanisms of action of statins has important implications in the prevention and treatment of mitochondrial oxidative stress-related illness such as DR. |
format | Text |
id | pubmed-2927955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-29279552011-09-01 Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α Zheng, Zhi Chen, Haibing Wang, Hong Ke, Bilian Zheng, Bingqing Li, Qian Li, Peiyu Su, Li Gu, Qing Xu, Xun Diabetes Complications OBJECTIVE: Mitochondrial reactive oxygen species (ROS) plays a key role in diabetic retinopathy (DR) pathogenesis. However, whether simvastatin decreases diabetes-induced mitochondrial ROS production remains uncertain. The aim of this study was to clarify the beneficial effects and mechanism of action of simvastatin against diabetes-induced retinal vascular damage. RESEARCH DESIGN AND METHODS: Diabetic rats and control animals were randomly assigned to receive simvastatin or vehicle for 24 weeks, and bovine retinal capillary endothelial cells (BRECs) were incubated with normal or high glucose with or without simvastatin. Vascular endothelial growth factor (VEGF) and peroxisome proliferator–activated receptor γ coactivator 1α (PGC-1α) in the rat retinas or BRECs were examined by Western blotting and real-time RT-PCR, and poly (ADP-ribose) polymerase (PARP), and p38 MAPK were examined by Western blotting. Mitochondrial membrane potential (Δψm) and ROS production were assayed using the potentiometric dye 5,5′,6,6′- Tetrachloro1,1′,3,3′-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1) or CM-H(2)DCFDA fluorescent probes. RESULTS: Simvastatin significantly upregulated PGC-1α (P < 0.01), subsequently decreased Δψm (P < 0.05) and ROS generation (P < 0.01), inhibited PARP activation (P < 0.01), and further reduced VEGF expression (P < 0.01) and p38 MAPK activity (P < 0.01). Those changes were associated with the decrease of retinal vascular permeability, retinal capillary cells apoptosis, and formation of acellular capillaries. CONCLUSIONS: Simvastatin decreases diabetes-induced mitochondrial ROS production and exerts protective effects against early retinal vascular damage in diabetic rats in association with the inhibition of mitochondrial ROS/PARP pathway mediated by PGC-1α. The understanding of the mechanisms of action of statins has important implications in the prevention and treatment of mitochondrial oxidative stress-related illness such as DR. American Diabetes Association 2010-09 2010-06-21 /pmc/articles/PMC2927955/ /pubmed/20566666 http://dx.doi.org/10.2337/db10-0638 Text en © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Complications Zheng, Zhi Chen, Haibing Wang, Hong Ke, Bilian Zheng, Bingqing Li, Qian Li, Peiyu Su, Li Gu, Qing Xu, Xun Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α |
title | Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α |
title_full | Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α |
title_fullStr | Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α |
title_full_unstemmed | Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α |
title_short | Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator–Activated Receptor γ Coactivator 1α |
title_sort | improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator–activated receptor γ coactivator 1α |
topic | Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927955/ https://www.ncbi.nlm.nih.gov/pubmed/20566666 http://dx.doi.org/10.2337/db10-0638 |
work_keys_str_mv | AT zhengzhi improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT chenhaibing improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT wanghong improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT kebilian improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT zhengbingqing improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT liqian improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT lipeiyu improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT suli improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT guqing improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a AT xuxun improvementofretinalvascularinjuryindiabeticratsbystatinsisassociatedwiththeinhibitionofmitochondrialreactiveoxygenspeciespathwaymediatedbyperoxisomeproliferatoractivatedreceptorgcoactivator1a |